Rik RADEMAKER
28Patents
8h-index
35Co-inventors
67Inventor score
Filing activity: Jan 8, 2015 → Oct 5, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10407501B2 | Humanized or chimeric CD3 antibodies | Physics | 13 | Active |
| US10358484B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
| US10358483B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
| US10364285B2 | Antibodies for the treatment of synucleinopathy | Physics | 12 | Active |
| US10358482B2 | Antibodies for the treatment of synucleinopathy | Physics | 11 | Active |
| US10544220B2 | Bispecific antibodies against CD3 and CD20 | Chemistry; Metallurgy | 9 | Active |
| US10800836B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 9 | Active |
| US10647763B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 8 | Active |
| US10647764B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 8 | Active |
| US10640554B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 8 | Active |
| US11091557B2 | Methods of producing multispecific antibodies against CD40 and CD137 | Chemistry; Metallurgy | 6 | Active |
| US11421024B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 5 | Active |
| US11542323B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 5 | Active |
| US11524995B2 | Agents, uses and methods for the treatment of synucleinopathy | Physics | 5 | Active |
| US11084882B2 | Multispecific antibodies against CD40 and CD137 | Chemistry; Metallurgy | 4 | Active |
| US11359015B2 | Humanized or chimeric CD3 antibodies | Chemistry; Metallurgy | 4 | Active |
| US10882913B2 | Anti-DR5 antibodies and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US11613575B2 | Humanized or chimeric CD3 antibodies | Physics | 3 | Active |
| US11008399B2 | Antibodies | Chemistry; Metallurgy | 2 | Active |
| US11440966B2 | Multispecific antibodies against CD40 and CD137 | Chemistry; Metallurgy | 2 | Active |
| US11130819B2 | Antibodies | Chemistry; Metallurgy | 1 | Active |
| US12247080B2 | Anti-DR5 antibodies and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11459395B2 | Binding agents binding to PD-L1 and CD137 and use thereof | Chemistry; Metallurgy | 0 | Active |
| US11970544B2 | Antibodies | Chemistry; Metallurgy | 0 | Active |
| US11939388B2 | Multispecific antibodies against CD40 and CD137 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.